International law firm Clifford Chance has advised long-standing client Informa, the international B2B Markets, Knowledge Services and Business Intelligence Group, on the divestment of Pharma Intelligence, its largest business within the Informa Intelligence division to Warburg Pincus for £1.9bn,and on the share buyback programme announced in conjunction with the disposal. This transaction will play a key part in Informa’s 2021-2024 Growth Acceleration Plan II, and provide funds to accelerate investment and expansion in two priority areas: Academic Markets & Knowledge Services (Taylor & Francis) and B2B Markets & Digital Services (Informa Markets, Informa Connect, Informa Tech). The proceeds of sale
The post Clifford Chance advises Informa on the divestment of Pharma Intelligence for £1.9 billion to Warburg Pincus appeared first on Legal Desire.